Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care

NCT02923804 is registered in ClinicalTrials.gov with Pronova BioPharma as lead sponsor.

NCT NCT02923804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02923804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients When Added to Standard of Care
Lead sponsor
Pronova BioPharma
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
December 1, 2017
Enrollment
172 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver